Untangling population structure and genetic diversity of reticulocyte binding protein 2b (PvRBP2b) erythrocytic stage vaccine candidate in worldwide Plasmodium vivax isolates
Open Access
- 29 March 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (3) , e0266067
Abstract
Backgrounds: Plasmodium vivaxis the predominantPlasmodiumspecies distributed extensively in the Americas and Asia-Pacific areas. Encoded protein byPlasmodium vivaxReticulocyte Binding Proteins (PvRBPs) family member are of critical prominence to parasite invasion and have been considered the significant targets in development of malaria vaccine for the blood stage. As high genetic polymorphism of parasites may impede the effectiveness of vaccine development, more research to unraveling genetic polymorphism ofpvrbp2bfrom various geographical regions seems indispensable to map the exact pattern of field isolates.Methodology/Principal findings: The aim of this study was to determine the sequences of Iranianpvrbp2b(nt: 502–1896) gene and then, to ascertain polymorphism ofpvrbp2bgene, recombination, the level of genetic distances, evaluation of natural selection, and the prediction of B-cell epitopes of Iranian and globalP.vivaxisolates.Pvrbp2bpartial gene was amplified and sequenced from 60 IranianP.vivaxisolates. Iranianpvrbp2bsequences as well as 95 published sequences from five countries were used to evaluate the genetic diversity and neutral evolution signature in worldwide scale. A total of 38 SNPs were identified among 60 Iranianpvrbp2bsequences (32 non-synonymous and 6 synonymous mutations), and 32 amino acid substitutions were observed in 29 positions as compared to Sal-1 sequence. Worldwide sequence analysis showed that 44 amino acid changes had occurred in 37 positions of which seven polymorphic sites had trimorphic mutations while the rest was dimorphic. The overall nucleotide diversity for Iranian isolates was 0.00431 ± 0.00091 while the level of nucleotide diversity was ranged from 0.00337 ± 0.00076 (Peru) to 0.00452 ± 0.00092 (Thailand) in global scale.Conclusions/Significance: Of amino acid substitutions, 12 replacements were located in the B-cell epitopes in which nine polymorphic sites were positioned in N-terminal and three polymorphic sites in predicted B-cell epitopes of C-terminal, signifying both variable and conserved epitopes for vaccine designing. Using the achieved outcome of the current investigation interrogate questions to the selection of conserved regions ofpvrbp2band understanding polymorphism and immune system pressure to pave a way for developing a vaccine based on PvRBP2b candidate antigen.Keywords
Funding Information
- Iran National Science Foundation (99001732)
This publication has 43 references indexed in Scilit:
- Global Population Structure of the Genes Encoding the Malaria Vaccine Candidate, Plasmodium vivax Apical Membrane Antigen 1 (PvAMA1)PLOS Neglected Tropical Diseases, 2013
- The Evolutionary History of Plasmodium vivax as Inferred from Mitochondrial Genomes: Parasite Genetic Diversity in the AmericasMolecular Biology and Evolution, 2013
- MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and UsabilityMolecular Biology and Evolution, 2013
- Genetic diversity and population structure of genes encoding vaccine candidate antigens of Plasmodium vivaxMalaria Journal, 2012
- Genetic Diversity in New Members of the Reticulocyte Binding Protein Family in Thai Plasmodium vivax IsolatesPLOS ONE, 2012
- Costs analysis of the treatment of imported malariaMalaria Journal, 2012
- A Research Agenda for Malaria Eradication: VaccinesPLOS Medicine, 2011
- Genetic polymorphism and effect of natural selection at domain I of apical membrane antigen-1 (AMA-1) in Plasmodium vivax isolates from MyanmarActa Tropica, 2010
- DnaSP v5: a software for comprehensive analysis of DNA polymorphism dataBioinformatics, 2009
- Haplotype diversity and SNP frequency dependence in the description of genetic variationEuropean Journal of Human Genetics, 2004